This finding was largely driven by congestive heart failure ... The utility of diuretic therapy in preventing heart failure is now well accepted and it is possible in this trial that doxazosin ...

Congestive heart failure (CHF) is when the heart does not ... symptoms, types, and treatment. Fluid builds up in the lungs and causes shortness of breath, even when a person is resting ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

Inspra (eplerenone tablets; Pfizer, Inc., New York, NY) is an aldosterone blocker that works by binding at the mineralocorticoid receptor. It has some similarities to the potassium-sparing ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...

DALLAS More than 56 million people globally live with heart failure (HF), which prevents the body from getting enough of the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

DALLAS, March 27, 2025 — More than 56 million people globally live with heart failure (HF), which prevents ... can be slowed with the right treatment. Research shows that outcomes for patients ...